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There was a significant reduction in 24-h blood pressure of 6 (2-10)/4 (2-6)mm Hg and day blood pressure of 7 (3-12)/5 (3-7)mm Hg (P=0.01), whereas night blood pressure remained unchanged
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Current Clinical Pharmacology, 2019, Vol. 14, No. 2 iii An insignificant reversible reduction in GFR of 3 ml/min/1.73m2 from 64 (27) ml/min/1.73m 2 was observed Ustundag et al.
[41]
The Effects of Spironolactone on Neph- The pre-specified secondary outcome of hyperkalaemia leading to discontinuation was not observed in the placebo and finerenone 10-mg/d groups; incidences in the finerenone 7.5-, 15, and 20-mg/d groups were 2.1%, 3.2%, and 1.7%, respectively
